Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Ashley Biden visited her late brother Beau Biden’s grave amid their father, Joe Biden, ongoing battle with stage 4 prostate ...

A veteran's metastatic prostate cancer diagnosis highlights the importance of PSA screening, early detection and informed ...

Researchers have identified a change in the way cells make proteins that may help prostate cancer become more aggressive and resist treatment. The finding points to a possible vulnerability in cancers ...

Significant variation seen by race, with increased likelihood of MRI in non-Hispanic Whites versus non-Hispanic Blacks ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...

Alicia Morgans, MD, MPH, discusses quality-of-life analyses from the ARANOTE and ARASENS trials and what they show about adding darolutamide (Nubeqa) to androgen deprivation therapy (ADT) in ...

Allen Khodab, MD discussed how patients with larger prostates had reduced IPSS scores that normalized to the same level as ...

After Nivea confirmed that she had been diagnosed with chronic myeloid leukemia, the "Complicated" singer shared that she is ...

These findings show how AI applications ... can support clinicians at one of the most consequential decision points in ...